Top Markets
Coin of the day
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.

Odonate Therapeutics, Inc.

ODTC
Rank in Stocks #18158
Odonate Therapeutics, Inc., a pharmaceutical company established in 2013 and... Odonate Therapeutics, Inc., a pharmaceutical company established in 2013 and headquartered in New York, New York, is dedicated to creating treatments for cancer. Its primary therapeutic in development is tesetaxel, an orally administered chemotherapy drug. This agent is currently undergoing a Phase III clinical study for its application in patients suffering from metastatic breast cancer.
Share Price
$150,000
Last synced: 2025-02-11
Market Cap
$210.38M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Odonate Therapeutics, Inc. (ODTC)

Category

Price of ODTC with the market cap of B
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
ODTC
$150,000
Market Capitalization of Odonate Therapeutics, Inc.(ODTC)
Market Cap: $210.38M
As of September 2026 Odonate Therapeutics, Inc. has a market cap of $210.38M. This makes Odonate Therapeutics, Inc. the world's 18158th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Odonate Therapeutics, Inc. from 2017 to 2026
ODTC compared with Top 5 Most Popular stocks
Price of ODTC Asset B Mkt. of B Results
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
$3,868,967,867 $210.38M
$5.424T +2,579,211.91%
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
$3,406,481,848 $210.38M
$4.776T +2,270,887.90%
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
$2,890,024,074 $210.38M
$4.052T +1,926,582.72%
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
$2,632,695,385 $210.38M
$3.691T +1,755,030.26%
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
$1,957,377,875 $210.38M
$2.744T +1,304,818.58%